Interferon Lambda 2 (IFNL2) Antibody

221€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Interferon Lambda 2 (IFNL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx323562
tested applications
ELISA, WB
Description
IFNL2 Antibody is a Rabbit Polyclonal against IFNL2.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Interferon Lambda 2 (IFNL2) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | ELISA: 1/20000, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Purified by affinity chromatography. |
Size 1 | 50 µg |
Size 2 | 100 µg |
Form | Liquid |
Tested Applications | ELISA, WB |
Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q8IZJ0 |
Gene ID | 282616 |
Alias | IL28A,IFNL2a,IFNL3a,IFN-lambda-2,Cytokine Zcyto20,Interleukin-28A |
Background | Antibody anti-IFNL2 |
Status | RUO |
Descripción
Interferon Lambda 2 (IFNL2), also known as IL-28A, is part of the Type III interferon family, a group of cytokines that play crucial roles in the innate immune response, particularly in antiviral defense. Type III interferons, which include IFNL1 (IL-29), IFNL2 (IL-28A), IFNL3 (IL-28B), and IFNL4, are structurally distinct from Type I interferons (e.g., IFN-α and IFN-β) but share similar antiviral functions. The key difference between Type I and Type III interferons lies in their receptor usage and the cell types they target. IFNL2 acts by stimulating the immune response primarily in epithelial cells, which form a protective barrier in various organs, including the lungs, intestines, and liver. This makes it particularly important in defending against viral infections that enter the body via mucosal surfaces, such as respiratory and gastrointestinal viruses. IFNL2 has been shown to restrict the replication of viruses like hepatitis B virus (HBV), hepatitis C virus (HCV), influenza virus, and SARS-CoV-2, making it an essential player in antiviral immunity.
Related Products

Human IL-28A (Interleukin-28A) ELISA Kit
Ver Producto
IL-28A antibody
Ver Producto